lung cancer | |||||
新闻 | |||||
FDA Issues CRL to Patritumab Deruxtecan in Advanced EGFR-Mutated NSCLC Findings from the HERTHENA-Lung01 presented during the 2023 World Conference on Lung Cancer (WCLC) and simultaneously published in the Journal of ...
| |||||
Idaho health system uses robots for early cancer detection East is the medical director for Pulmonary Critical Care and Sleep Medicine. "This system is going to allow us to diagnose lung abnormalities early ...
| |||||
Abdera Therapeutics Announces FDA Fast Track Designation for ABD-147, a Next ... - StreetInsider ... carcinoma (LCNEC) who previously received platinum-based therapy. About Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma. The global ...
| |||||
Merck, Daiichi lung cancer therapy rejected in U.S. (NYSE:MRK) | Seeking Alpha Merck (MRK) and Daiichi Sankyo (DSKYF) have failed to secure FDA nod for their lung cancer drug HER3-DXd due to manufacturing concerns.
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment